Dergiler / Celal Bayar Üniversitesi Fen Bilimleri Dergisi / 2021 / Cilt: 17 - Sayı: 1

Attenuation of Docetaxel-induced Oxidative Stress and Apoptosis in HEK 293 Human Embryonic Kidney Cells by Curcumin Treatment

Sayfa
73–78
Yayın Tarihi
2020-12-30
DOI
—
🏛️Bu makalenin bibliyografik verileri ve tam metin bağlantısı DergiPark üzerinden sağlanmıştır.
DergiPark Kaydı ↗
✨

Yapay Zeka Hızlı Bakış & Çıkarımlar

AI Insight
⚡ TL;DR(1 Cümlede Hızlı Çıkarım)

Thus, this study highlights the novel pharmacological mechanisms of CUR and understanding the detailed mechanisms of CUR action could lead to novel renoprotective interventions.

📌 3 Maddede Bu Makale

🎯
Amaç & Hipotez:Docetaxel (DOC) is a chemotherapeutic that induces microtubule stabilization.
📊
Temel Bulgular & Veri:Here, the possible preventive effect of CUR against DOC-induced oxidative stress and apoptosis on HEK-293 immortalized human embryonic kidney cells.
💡
Sonuç & Katkı:Thus, this study highlights the novel pharmacological mechanisms of CUR and understanding the detailed mechanisms of CUR action could lead to novel renoprotective interventions.
🔬Tür:Araştırma Makalesi
📍Kapsam:Genişletilmiş Akademik Örneklem
⚙️Değişkenler:Apoptosis · curcumin · docetaxel

Abstract

Docetaxel (DOC) is a chemotherapeutic that induces microtubule stabilization. It is often used in breast, prostate, lung and gastric cancers but severe side effects such as cardiotoxicity, neurotoxicity, hepatotoxicity, and nephrotoxicity limit its usage. Curcumin (CUR), a natural bioactive compound derived from turmeric. Here, the possible preventive effect of CUR against DOC-induced oxidative stress and apoptosis on HEK-293 immortalized human embryonic kidney cells. Viability was assessed via MTT assay. The generation of ROS was measured by CM-H2DCFDA dye. Phosphatidylserine externalization and caspase 3/7 activity were used to measure apoptosis. CUR pretreatment remarkably inhibited DOC-induced cell viability reduction, ROS generation, and cell apoptosis in HEK-293 cells. Moreover, this study revealed that CUR pretreatment decreased the caspase-3 activity. Thus, this study highlights the novel pharmacological mechanisms of CUR and understanding the detailed mechanisms of CUR action could lead to novel renoprotective interventions.

🔖

Bu Makaleye Atıf Yap

İLHAN, S. (2020). Attenuation of Docetaxel-induced Oxidative Stress and Apoptosis in HEK 293 Human Embryonic Kidney Cells by Curcumin Treatment. Celal Bayar Üniversitesi Fen Bilimleri Dergisi, Cilt: 17 - Sayı: 1, 73–78. https://ajindex.com/articles/116485

📄 Tam Metin PDF Okuyucu

📄

PDF görüntüleyici hazırlanıyor...

Kaynakça (15)

  1. Bray, F, Ferlay, J, Soerjomataram, I, Siegel, RL, Torre, LA, Jemal, A. 2018. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA: A Cancer Journal for Clinicians; 68(6): 394-424
  2. Monsuez, JJ, Charniot, JC, Vignat, N, Artigou, JY. 2010. Cardiac side-effects of cancer chemotherapy. International Journal of Cardiology; 144(1): 3-15
  3. Love, RR, Leventhal, H, Easterling, DV. Nerenz, DR. 1989. Side effects and emotional distress during cancer chemotherapy. Cancer; 63(3): 604-612
  4. Oun, R, Moussa, YE. Wheate, NJ. 2018. The side effects of platinum-based chemotherapy drugs: a review for chemists. Dalton Transactions; 47(19): 6645-6653
  5. Cheok, CF. 2012. Protecting normal cells from the cytotoxicity of chemotherapy. Cell Cycle; 11(12): 2227-2227
  6. Saloustros, E, Mavroudis, D, Georgoulias, V. 2008. Paclitaxel and docetaxel in the treatment of breast cancer. Expert Opinion on Pharmacotherapy; 9(15): 2603-2616
  7. Saloustros, E, Georgoulias, V. 2008. Docetaxel in the treatment of advanced nonsmall-cell lung cancer. Expert Review of Anticancer Therapy; 8(8): 1207-1222
  8. Yin, H, Guo, R, Xu, Y, Zheng, Y, Hou, Z, Dai, X, Zhang, Z, Zheng, D, Xu, HE. 2012. Synergistic antitumor efficiency of docetaxel and curcumin against lung cancer. Acta Biochimica et Biophysica Sinica; 44(2): 147-153
  9. Baker, SD, Verweij, J, Cusatis, GA, van Schaik, RH, Marsh, S, Orwick, SJ, Franke, RM, Hu, S, Schuetz, EG, Lamba, V, Messersmith, WA, Wolff, AC, Carducci, MA, Sparreboom, A. 2009. Pharmacogenetic pathway analysis of docetaxel elimination. Clinical Pharmacology & Therapeutics; 85(2): 155-163
  10. Takimoto, T., Nakabori, T., Osa, A., Morita, S., Terada, H., Oseto, S., Iwazawa, T. Abe, K., 2012. Tubular nephrotoxicity induced by docetaxel in non-small-cell lung cancer patients. International Journal of Clinical Oncology; 17(4): 395-398
  11. Pabla, N, Dong, Z. 2008. Cisplatin nephrotoxicity: mechanisms and renoprotective strategies. Kidney International; 73(9): 994-1007
  12. Aggarwal, BB, Kumar, A, Bharti, AC. 2003. Anticancer potential of curcumin: preclinical and clinical studies. Anticancer Research; 23(1/A): 363-398
  13. Basnet, P, Skalko, BN. 2011. Curcumin: An anti-inflammatory molecule from a curry spice on the path to cancer treatment. Molecules; 16(6): 4567-4598
  14. Araujo, C, Leon, L. 2001. Biological activities of Curcuma longa L. Memórias do Instituto Oswaldo Cruz; 96(5): 723-28
  15. Joe, B, Vi